Status:
UNKNOWN
Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone
Lead Sponsor:
Atrium Medical Center
Conditions:
Abortion, Induced
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.
Eligibility Criteria
Inclusion
- Pregnant women by whom a termination of pregnancy is desired.
Exclusion
- Women with liver/kidney disease
- Women on long-term use of corticosteroids (\> 6 months)
- Cardiovascular problems
- Therapy-resistant diabetic women
- Therapy-resistant asthma/bronchitis
- Thalassemia
- Ulcerative colitis
- Peptic ulcer disease
- Glaucoma
- Porphyria
- Allergic reaction to prostaglandin or mifepristone
- Women with a prior caesarian section or women with contractions at the start of the study
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00206193
Last Update
October 30 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Atrium Medisch Centrum
Heerlen, Limburg, Netherlands